An international research consortium, led by scientists at VIB and UGent, has developed a new platform that could change how ...

"In India, snakebites are seen as a poor person's problem," Jain says. "That's why there isn't enough outrage or action over these completely avoidable deaths. When it comes to treating snakebites, ...

Regeneron Pharmaceuticals, Inc. targets double-digit 2026 growth via Dupixent expansion and fewer Eylea headwinds. Check out ...

A heart attack activates stress circuits in the brain that evolved for survival but can amplify inflammation, disrupt healing ...

API keys and credentials. Agents operate inside authorized permissions where firewalls can't see. Traditional security models ...

Learn how to manage an IgA nephropathy flare with this detailed action plan. Understand symptoms and prevention to safeguard ...

Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and outcomes for patients who have ...

Elevar Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for Rivoceranib in Combination with Camrelizumab as a First-line Systemic Treatment for Unresectable Hepatocellular ...

Ivonescimab's BLA acceptance is a milestone for PD-1/VEGF bispecific antibodies in the U.S., potentially transforming ...

Kyowa Kirin affirms commitment to developing rocatinlimab as a life-changing differentiated asset with significant market ...

Veterinary biologics fall under stringent regulatory frameworks that can affect approval timelines and commercial strategies.

Allergic diseases represent a major global health burden, placing significant strain on healthcare systems worldwide. Severe ...